Antenatal syphilis screening using point-of-care testing in Sub-Saharan African countries: a cost-effectiveness analysis.

by Andreas Kuznik, Mohammed Lamorde, Agnes Nyabigambo, Yukari C Manabe
Published 2013-11-01

Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial

by Pauline Byakika-Kibwika, Patience Nyakato, Mohammed Lamorde, Agnes N. Kiragga
Published 2018-10-01

Update on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria

by Pauline Byakika-Kibwika, Mohammed Lamorde, Harriet Mayanja-Kizza, et al
Published 2009-12-01

Piperaquine concentration and malaria treatment outcomes in Ugandan children treated for severe malaria with intravenous Artesunate or quinine plus Dihydroartemisinin-Piperaquine

by Pauline Byakika-Kibwika, Ronald Ssenyonga, Mohammed Lamorde, Daniel Blessborn, Joel Tarning
Published 2019-12-01

Antenatal syphilis screening using point-of-care testing in low- and middle-income countries in Asia and Latin America: a cost-effectiveness analysis.

by Andreas Kuznik, Christine Muhumuza, Henry Komakech, Elsa M R Marques, Mohammed Lamorde
Published 2015-01-01

Cost-effectiveness of antivenoms for snakebite envenoming in Nigeria.

by Abdulrazaq G Habib, Mohammed Lamorde, Mahmood M Dalhat, Zaiyad G Habib, Andreas Kuznik
Published 2015-01-01

Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis.

by Yukari C Manabe, Sabine M Hermans, Mohammed Lamorde, Barbara Castelnuovo, C Daniel Mullins, Andreas Kuznik
Published 2012-01-01

Leveraging investments in Ebola preparedness for COVID-19 in Sub-Saharan Africa [version 1; peer review: 3 approved]

by Rodgers Ayebare, Peter Waitt, Stephen Okello, Mubaraka Kayiira, Maureen Atim Ajok, Irene Nakatudde, Nahid Bhadelia, Mohammed Lamorde
Published 2020-03-01

Evaluation of the Management of Patients with Detectable Viral Load after the Implementation of Routine Viral Load Monitoring in an Urban HIV Clinic in Uganda

by Nsumba Steven Mark, Musomba Rachel, Arvind Kaimal, Mubiru Frank, Tibakabikoba Harriet, Lwanga Isaac, Mohammed Lamorde, Castelnuovo Barbara
Published 2019-01-01

“You would not be in a hurry to go back home”: patients’ willingness to participate in HIV/AIDS clinical trials at a clinical and research facility in Kampala, Uganda

by Deborah Ekusai Sebatta, Godfrey Siu, Henry W. Nabeta, Godwin Anguzu, Stephen Walimbwa, Mohammed Lamorde, Badru Bukenya, Andrew Kambugu
Published 2020-08-01

Cost effectiveness of a pharmacy-only refill program in a large urban HIV/AIDS clinic in Uganda.

by Joseph B Babigumira, Barbara Castelnuovo, Andy Stergachis, Agnes Kiragga, Petra Shaefer, Mohammed Lamorde, Andrew Kambugu, Alice Muwanga, Louis P Garrison
Published 2011-03-01

Cost-effectiveness of expanding childhood routine immunization against Neisseria meningitidis serogroups C, W and Y with a quadrivalent conjugate vaccine in the African meningitis...

by Andreas Kuznik, Garba Iliyasu, Mohammed Lamorde, Mustapha Mahmud, Baba M Musa, Ibrahim Nashabaru, Stephen Obaro, Idris Mohammed, Abdulrazaq G Habib
Published 2017-01-01

Impact of a mobile phone-based interactive voice response software on tuberculosis treatment outcomes in Uganda (CFL-TB): a protocol for a randomized controlled trial

by Dathan Mirembe Byonanebye, Hope Mackline, Christine Sekaggya-Wiltshire, Agnes N. Kiragga, Mohammed Lamorde, Elizabeth Oseku, Rachel King, Rosalind Parkes-Ratanshi
Published 2021-06-01

Comparison of different cardiovascular risk tools used in HIV patient cohorts in sub-Saharan Africa; do we need to include laboratory tests?

by Frank Mubiru, Barbara Castelnuovo, Steven J Reynolds, Agnes Kiragga, Harriet Tibakabikoba, Noela Clara Owarwo, Andrew Kambugu, Mohammed Lamorde, Rosalind Parkes-Ratanshi
Published 2021-01-01

Pharmacokinetics, SAfety/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: stu...

by Ruth Nabisere, Joseph Musaazi, Paolo Denti, Florence Aber, Mohammed Lamorde, Kelly E. Dooley, Rob Aarnoutse, Derek J. Sloan, Christine Sekaggya-Wiltshire
Published 2020-02-01

Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa.

by Muhammad Hamza, Maryam A Idris, Musa B Maiyaki, Mohammed Lamorde, Jean-Philippe Chippaux, David A Warrell, Andreas Kuznik, Abdulrazaq G Habib
Published 2016-03-01

Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda

by Yussif Alhassan, Adelline Twimukye, Thoko Malaba, Catherine Orrell, Landon Myer, Catriona Waitt, Mohammed Lamorde, Andrew Kambugu, Helen Reynolds, Saye Khoo, Miriam Taegtmeyer
Published 2020-12-01

Engendering health systems in response to national rollout of dolutegravir-based regimens among women of childbearing potential: a qualitative study with stakeholders in South Afri...

by Yussif Alhassan, Adelline Twimukye, Thoko Malaba, Catherine Orrell, Landon Myer, Catriona Waitt, Mohammed Lamorde, Andrew Kambugu, Helen Reynolds, Saye Khoo, Miriam Taegtmeyer
Published 2020-08-01

An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing rit...

by Eva Agnes Odongpiny Laker, Maria Sarah Nabaggala, Arvind Kaimal, Damalie Nalwanga, Barbara Castelnuovo, Abdu Musubire, Agnes Kiragga, Mohammed Lamorde, Rosalind Parkes- Ratanshi
Published 2019-03-01

Case Report: Three's a crowd: a case report examining the diagnostic and pharmacokinetic challenges in HIV-tuberculous meningitis-malaria co-infection [version 2; referees: 2 appro...

by Jayne Ellis, Prosperity C. Eneh, Kenneth Ssebambulidde, Morris K. Rutakingirwa, Mohammed Lamorde, Joshua Rhein, Fiona V. Cresswell, David R. Boulware, Melanie R. Nicol
Published 2019-01-01